- Recommendation ID
- NG228/03
- Question
Nimodipine: What is the clinical and cost effectiveness of nimodipine in the management of aneurysmal subarachnoid haemorrhage?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on nimodipine.
Full details of the evidence and the committee's discussion are in evidence review D: medical management strategies.
Source guidance details
- Comes from guidance
- Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management
- Number
- NG228
- Date issued
- November 2022
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/11/2022 |